Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: Japan Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20072
20082
20092
20103
20112
20121
20141
20153
20163
20173
20191
20201
20211
20223
20234
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated6
Active, not recruiting4
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer7
GlaxoSmithKline6
Merck Sharp & Dohme LLC4
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Actelion3
Insmed Incorporated3
Novartis Pharmaceuticals3
Biogen2
GB002, Inc.1
Gossamer Bio USA, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension40
Hypertension, Pulmonary17
Cardiovascular Diseases1
Eisenmenger Complex1

Trials

Showing 51 to 40 of 40. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.